Indications: Rylaze is an asparagine-specific enzyme indicated as a component of a multi-agent chemotherapy regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients with a history of hypersensitivity to Escherichia coli-derived asparaginase for 1 month or longer.
Let us work together to protect precious health